當(dāng)前位置：   首頁(yè) > 需求大廳

本人需要申報(bào)一種臟器提取物中化合物專(zhuān)利的技術(shù)指導(dǎo)（化學(xué)），有意者請(qǐng)與我聯(lián)系   [更多]

具體要求： 需要?jiǎng)┬停浩瑒?，酒劑，膠囊，搽劑。   [更多]

求購(gòu)特戊酸、特戊酰氯、氯代特戊酰氯、亞磷 酸、叔碳酸等生產(chǎn)技術(shù) ，信息真實(shí)有效，經(jīng)驗(yàn)證后可付款。具體金額請(qǐng)報(bào)價(jià)。   [更多]

求購(gòu)鄰對(duì)氯苯腈成熟大生產(chǎn)工藝，信息真實(shí)有效，經(jīng)驗(yàn)證后可付款。具體金額請(qǐng)報(bào)價(jià)。   [更多]

求購(gòu)氯化鋅工業(yè)化生產(chǎn)技術(shù)，信息真實(shí)有效，經(jīng)驗(yàn)證后可付款。具體金額請(qǐng)報(bào)價(jià)。   [更多]

我需要全國(guó)各城市的醫(yī)院銷(xiāo)售數(shù)據(jù)，尋找可以長(zhǎng)期提供各城市銷(xiāo)售數(shù)據(jù)的合作者，城市數(shù)據(jù)要求是樣本城市的銷(xiāo)售總數(shù)據(jù)，數(shù)據(jù)真實(shí)可靠，齊全。 如果能長(zhǎng)期提供該數(shù)據(jù)的，請(qǐng)投稿，具體價(jià)格等事宜單獨(dú)聯(lián)系。   [更多]

詳細(xì)說(shuō)明:所得產(chǎn)品水分不能超過(guò)2.5%，成鹽或精制溶劑最好用三類(lèi)溶劑。成熟工藝，驗(yàn)證付款   [更多]

詳細(xì)說(shuō)明：1、符合大生產(chǎn)技術(shù)要求。 2、物料成本能控制在400元左右。 3、可以進(jìn)行交接。驗(yàn)證后付款   [更多]

詳細(xì)說(shuō)明：中式工藝，成本有優(yōu)勢(shì)。成熟工藝。驗(yàn)證后付款   [更多]

當(dāng)心血管疾?。ㄐ呐K病或中風(fēng)）確診后，醫(yī)生會(huì)提供治療建議，但病人的決定是至關(guān)重要的。美國(guó)心臟協(xié)會(huì)（AHA）與 以病人為中心的成果研究所（PCORI）合作，網(wǎng)絡(luò)征集文章。你可以是患者，社區(qū)志愿者，家庭成員或任何人，只要你有這方面的親身經(jīng)驗(yàn)。根據(jù)你的情況來(lái)闡述患者的治療決策是怎樣做出的，例如：對(duì)壽命的影響，對(duì)生活質(zhì)量的影響，費(fèi)用，或其他？同時(shí)關(guān)心過(guò)程的完整性，時(shí)間，等等。。。 “請(qǐng)于2016年6月9日之前將稿件上傳到：https://www.innocentive.com/ar/workspace/challengeDetail?challenge=9933835“ THE CHALLENGE Treatment of heart disease and stroke often requires patients and their families to make many decisions on how to move forward after a cardiac event. Specifically, AHA and PCORI are interested in learning about the “decisional dilemmas” you face – your insights will help guide future research to improve heart health. Based on the input from you and others in the patient and caregiver community, we will identify important concerns and use the perspectives to target research towards what matters most. Despite multiple available treatment options that your physician may describe, you may not always know which option is right/best for you. Tell us about the most difficult decision that you or your family faced when evaluating treatment options for heart disease or stroke. In addition, we would like to understand more about what you considered most important when making this choice or decision. Please pick your top three choices and tell us why they are important to you and your family: Side effects of the treatment Complexity of treatment plan Difficulty in adhering to a treatment Impact on my quality of life Potential to prolong my life Whether the best option for me is selected based on research of people similar to me (personal characteristics such as my age, race and gender) Whether my family history and genetic makeup would influence the effectiveness of a given option Whether a trusted source recommended a specific option The financial impact of the options for me and my family Other:________ Any submission should address the following Submission Requirements: The submission can be from anyone (patient, caregiver, family member, or other)   [更多]